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Abstract
Macrophages are specialized antigen-presenting cells that process and present self-anti-
gens for induction of tolerance, and foreign antigens to initiate T cell-mediated immunity.
Despite this, Leishmania donovani (LD) are able to parasitize the macrophages and persist.
The impact of this parasitizing and persistence on antigen processing and presentation by
macrophages remains poorly defined. To gain insight into this, we analyzed by liquid chro-
matography tandem mass spectrometry (LC-MS/MS) and compared the HLA-I self-pepti-
domes, proteasome compositions, HLA expression and activation states of non-infected
and LD-infected THP1-derived macrophages. We found that, though both HLA-I pepti-
domes were dominated by nonapeptides, they were heterogeneous and individualized, with
differences in HLA binding affinities and anchor residues. Non-infected and LD-infected
THP1-derived macrophages were able to sample peptides from source proteins of almost
all subcellular locations and involved in various cellular functions, but in different propor-
tions. In the infected macrophages, there was increased sampling of plasma membrane
and extracellular proteins, and those involved in immune responses, cell communication/
signal transduction and metabolism/energy pathways, and decreased sampling of nuclear
and cytoplasmic proteins and those involved in protein metabolism, RNA binding and cell
growth and/or maintenance. Though the activation state of infected macrophages was
unchanged, their proteasome composition was altered.
Introduction
Visceral leishmaniasis (VL) is a vector-borne neglected tropical and subtropical disease caused
by Leishmania donovani (LD) and other Leishmania species that are transmitted by infected
female phlebotomine sandflies and obligate intracellular protozoan parasites in vertebrates [1].
It is the second largest parasitic killer disease after malaria, with 200 000 to 400 000 estimated
new cases each year. The infections result in high fatality [1–3] that is prone to worsen with
HIV/VL and other co-infection [4–7].
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When promastigote forms of LD are taken up by the macrophages they are internalized
into phagolysosomes where they transform into non-motile amastigotes. The amastigotes sur-
vive the harsh milieu in the phagolysosome, multiply, and eventually rupture the macrophages
and infect the new macrophages [8]. Survival and replication in the macrophage host is
through subversion of the host immune system and promotion of pro-parasitic host factors
[9]. This is achieved, among other mechanisms, by inhibiting the formation of nitric oxide
that plays a major role in killing intracellular parasites, suppressing apoptosis of the host cell,
and inhibiting production of cytokines thus interfering with cytokine-inducible macrophage
functions such as oxidative bursts [10–14].
Macrophages, as professional antigen-presenting cells, generate MHC class I and MHC
class II (HLA class I and II in humans) peptide complexes through various intracellular path-
ways and mechanisms. For MHC I peptide complexes, endogenous or cross-presented pro-
teins are processed via constitutive or immunoproteosomes. The resulting peptides are
transported into the endoplasmic reticulum by the transporter associated with antigen pro-
cessing (TAP), loaded onto MHC class I molecules (HLA I), and transported via the Golgi
apparatus and exocytic vesicles to the cell surface for presentation to CD8+ T cells [15]. The
collection of peptides presented by MHC molecules at the cell surface are termed HLA pepti-
domes or ligandomes. Though LD is able to parasitize the host macrophages and persist, its
impact on the host HLA-I peptidome remains undefined.
The human monocytic leukemia cell line THP1-derived macrophages (THP1MФ) are simi-
lar to native monocyte-derived macrophages [16–19], and have been used extensively as
model for studying human macrophage immune functions and responses towards intracellu-
lar pathogens [19, 20]. The THP1MФ could therefore serve to study and compare the self-pep-
tidomes of human macrophages infected and non-infected with LD, which would allow to
gain insights into how LD influences antigen processing and presentation.
Material and methods
Parasites
The wild type LD MHOM/IN/02/BHU5 (BHU5) [21] promastigotes were established from
splenic aspirates of an Indian patient and cultured in M199 culture medium (Gibco Invitro-
gen) supplemented with 20% heat-inactivated fetal bovine serum (Biochrom, Germany) at
25˚C. The yellow fluorescent protein (YFP) transfected LD (YFP-BHU5) promastigotes were
cultured in the dark in the same medium with 50μg/ml hygromycin.
Cell lines, differentiation and infection
The HeLa cell line clone 33/2 (HeLa A2+/IP) that stably expresses the three inducible subunits
LMP2, MECL1 and LMP7 [22] was kindly provided by Prof. P. M. Kloetzel (Charite´ - Univer-
stita¨tsmedizin Berlin, Germany). It was cultured in Iscove’s Basal medium (Biochrom Ger-
many) supplemented with 10% heat-inactivated fetal calf serum (Biochrom, Germany), 2 μg/
ml puromycin (Roche, Mannheim, Germany) and 300 μg/ml hygromycin (Roche, Mannheim,
Germany) at 37˚C in a humidified atmosphere with 8% CO2. The acute monocytic leukemia-
derived human cell line THP1 (ATCC TIB-202) was cultured in RPMI 1640 medium (Invitro-
gen, Karlsruhe, Germany) supplemented with 10% heat-inactivated fetal calf serum (Bio-
chrom, Germany) and 1% streptomycin-penicillin (Gibco Invitrogen, Germany) at the same
conditions. THP1 is homozygous for HLA-A02:01, HLA-B15:11 and HLA-C03:03 [23]. To
generate the THP1 macrophage phenotype (THP1MФ), THP1 cells were differentiated with
50 ng/ml phorbol-12-myristate-13-acetate (Sigma, Steinheim, Germany) for 48h. To infect
THP1MФ with the BHU5 or YFP-BHU5, parasites were harvested by centrifugation at 500 x g
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for 8 minutes, washed, re-suspended in RPMI 1640 medium (Invitrogen, Karlsruhe, Germany)
and added to the THP1MФ cultures at the ratio parasites: THP1MФ 10:1, and cultured for 48
h at 37˚C under 8% CO2. Subsequently, THP1MФ and YFP-BHU5 infected THP1MФ
(THP1MFiy) were used immediately to access the uptake of YFP-BHU5 by THP1MФ and its
effects on HLA-ABC and HLA-DR expression. THP1MФ and BHU5 infected THP1MФ
(THP1MFi) were used to access viability, HLA-ABC, HLA-A02:01 and CD83 expression,
and were harvested by 10 min centrifugation at 800 x g, shock-frozen in liquid nitrogen and
stored as pellets at -80˚C for isolation of HLA.
Parasite uptake, viability, activation and HLA expression
To determine the uptake of LD by THP1MF and effects on hosts viability, CD83, HLA-ABC,
HLA-A02:01 and HLA-DR expression flow cytometry was used. THP1MФ and THP1MFiy
or THP1MFi were stained with fluorochrome-labeled monoclonal antibodies against CD11b,
CD83, HLA-ABC (BD Bioscience, Heidelberg, Germany), HLA-A02:01 and HLA-DR (BioLe-
gend, Eching, Germany), Calcein-AM (Invitrogen, Carlsbad, CA, USA) and Propidium Iodide
(PI) (Sigma-Aldrich, Germany). The expression of these markers on the cell surface and of cal-
cein and PI fluorescence was determined with a FACSCalibur flow cytometer (Becton Dickin-
son, Heidelberg, Germany) on 20,000 for forward versus sideward scatter-gated events.
CellQuest (Becton Dickinson, Heidelberg, Germany) and WinMDi 2.9 (Purdue University,
USA) software were used to process and analyze the data, respectively. The uptake was assessed
by CD11b expression against YFP fluorescence, and cell viability assessed using Calcein-AM
(Invitrogen, Carlsbad, CA, USA) and propidium iodide (PI) (Sigma-Aldrich, Germany).
CD83 was used as a marker of macrophage activation.
Constitutive and immunoproteasome expression in THP1MФ and
THP1MФi
The impact of the infection by LD on the constitutive and immunoproteasome expression of
THP1MF was determined by semi-quantitative RT-PCR. Total RNA was extracted from
THP1MФ, THP1MФi, HeLa cell line, and HeLa clone 33/2 (A2+/IP) using Nucleospin RNA II
Purification Kit (Macherey-Nagel, Duren, Germany). cDNAs were prepared from 500ng of
DNase-treated RNA using superscript III reverse transcriptase (Invitrogen, CA, USA).
RT-PCR was carried out with 500ng of cDNA using the following constitutive (β1, β2 and β5)
and immunoproteasome (β1i, β2i and β5i) subunit-, and GADPH- specific forward and
reverse primers [24]. β1: GACTCCAGAACAACCACTG, CTTGGTCATGCCTTCCCG (399bp;
BC000835.2, NM_057099.2); β2: CTGAAGGGATGGTTGTTGC, CTTTCTCACACCTGTACCG
(558bp; D38048.1, NM_053532.1); β5: CCAAACTGCTTGCCAACATG, GAGTAGGCATCTCTG
TAGG (275 bp; D29011.1, XM_341314.3); Hsβ1i: CTACTGTGCACTCTCTGG, GCCTGGCTTA
TATGCTGC (313 bp; U01025); Hsβ2i: GAAGATCCACTTCATCGC, CTCCAGGGTTAGTGGCTTC
(571 bp; Y13640); Hsβ5i: GGAGAAAGGAACGTTCAG, TTGATTGGCTTCCCGGTAC (648 bp;
U17496); GAPDH: CCTTCATTGACCTCAACTAC, CACCACCCTGTTGCTGTAG (869 bp;
NM_002046.2, NM_017008.2). PTC-200 Peltier Thermal Cycler (BIO-RAD, Mu¨nchen, Ger-
many) was used. Thermocycling conditions were denaturation at 96˚C for 2 min, 30 cycles of
denaturation at 95˚C for 40 sec, primer annealing at 55˚C to 68˚C for 1 min, primer extension
at 72˚C for 40 sec and a final cycle of extension at 72˚C for 10 min. The amplified DNA frag-
ments were analyzed by electrophoresis using 1.2% agarose gels. HeLa cell line, and HeLa
clone 33/2 (A2+/IP) were used as positive controls for constitutive and immunoproteasome
subunits, respectively. GelAnayzer2010 (http://www.gelanalyzer.com/download.html) was use
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to semi-quantitatively analyze the subunit band intensities. For each subunit, the band inten-
sity was divided by the value for the GAPDH amplified in the same reaction tube.
Isolation, purification and LC-MS/MS analysis of HLA I-presented
peptides
Isolation of MHC I molecules was carried out as previously described [25, 26]. In brief, 2.3 x 109
shock frozen cells were lyzed in 0.3% CHAPS, 0.2% NP-40, 145 mM NaCl, 1 mM EDTA, 1mM
Pefabloc, 20 mM Tris-HCl buffer at pH 7.4 and ultracentrifuged for 1h at 100,000 x g. HLA I
molecules were purified from the supernatants using monoclonal antibody of irrelevant speci-
ficity for preclearing and HLA class I-specific mAb W6/32, respectively, coupled to CNBr-acti-
vated sepharose (Amersham Biosciences, Uppsala, Sweden). The anti-human HLA-I column
with HLA-peptide complexes was washed successively with 20mM Tris, 145 mM NaCl pH 7.4
(TBS), 0.3% CHAPS in TBS, TBS, 0.3% ß-octylglycoside in TBS, TBS and finally ultrapure
water. HLA-peptide complexes were eluted using 0.7% TFA in ultrapure water. Peptides were
isolated from high molecular weight components by ultrafiltration using centrifugal filters with
a 3-kDa molecular weight cut-off (Centricon, Millipore, Schwalbach, Germany). Filtrate frac-
tionates were obtained using an acetonitrile gradient of 5–90% of solvent B (90% acetonitrile,
0.1% TFA in ultrapure water) in solvent A (0.1% TFA in ultrapure water) with a reverse phase
column μRPC C2/C18, SC2.1/10 on a Smart HPLC system (Amersham Biosciences, Freiburg,
Germany). The peptide fractionates were analyzed by reverse phase liquid chromatography
(3000 nano-HPLC system; Dionex, Darmstadt, Germany) coupled on-line with MicroTOF-Q
mass spectrometer (Bruker Daltonics, Bremen, Germany). Peptide fractionates were injected
onto a C18 precolumn at 20 μL/min (2% acetonitrile, 0.05% TFA) for 5 min. Subsequently, pep-
tides were separated at a flow rate of 220nl/min onto a 75-μm × 15 cm PepMap nano-HPLC col-
umn with a gradient of 5–60% acetonitrile over 60 min, then 60–90% acetonitrile over 5 min
and finally 90% acetonitrile for 5 min, all with 0.1% formic acid in ultrapure water. Eluted pep-
tides were nanospray-ionized and fragmented based on the five most intense precursor ions sig-
nals, with a 1 min dynamic exclusion time to avoid repeated fragmentation.
Processing and analysis of data
MS and MS/MS spectra were processed using Data Analysis 3.4 and Biotools 3.1 (Bruker Dal-
tonics). Peptides were identified against Swissprot human protein sequence database version
56.3 (20,408 reviewed non-redundant protein sequences) integrated in a local MASCOT server
(version 2.2). Precursor and fragment mass tolerances of 100 ppm and 0.5 Da were used
respectively, oxidation of methionine was allowed as a possible modification. Peptide-spec-
trum matches were validated using a statistical evaluation -10logP, where logP is the logarithm
to the base 10 of P (P<0.05). De novo sequencing using Sequit software [27] and manual
inspection were used to further validate the identified peptides. Peptides source proteins were
annotated using Uniprot [28] and classified according to subcellular locations and biological
functions using human protein reference database [29]. Peptides were assigned to their respec-
tive HLA using netMHCpan in the Immune Epitope Database IEDB [30, 31] and SYFPEITHI
[32], and their predicted HLA binding affinities were determined using netMHCpan in IEDB
with a binding affinity IC50 threshold of 500nM. Binding motifs for the nonapeptides were
visualized using sequence logos [33, 34].
Statistical analyses
Macrophage activation, HLA expression and proteasome subunit expression between
THP1MФ and THP1MФi/or THP1MФiy were compared by paired 1-tailed Student’s t-test
HLA self-peptide repertoire of Leishmania-infected and non-infected human macrophages
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and differences indicated as significant when p< 0.05. Data are presented as the
mean ± standard deviation from three independent experiments.
Results
Parasite uptake and effects on viability, activation and HLA expression
To assess the uptake of LD by THP1MF and to determine its effects on viability and expres-
sion of HLA-ABC, HLA-A02:01, HLA-DR and CD83 by the host, flow cytometry was used as
detailed in Materials and Methods. The uptake of YFP-BHU5 by THP1MФ based on CD11b
expression versus the YFP fluorescence was 70.25±5.59%. The viability of THP1MФi was
slightly lower compared to THP1MФ based on calcein and PI fluorescence (Fig 1A). The levels
of HLA-ABC (p<0.05), HLA-DR and HLA-A02:01 were lower on the infected compared to
the non-infected cells, while those of the macrophage activation marker CD83 were
unchanged (Fig 1B and 1C). The decrease in MHC class I and II expression on infected cells
has also been observed previously, albeit in murine studies [14].
Impact of parasite uptake on constitutive and immunoproteasome mRNA
expression
To determine the impact of LD on the hosts constitutive and immunoproteasome subunit
expression by THP1MF, semi-quantitative RT-PCR was carried out as detailed in Materials
and Methods. THP1MФ and THP1MФi expressed both the constitutive proteasome subunits
(β1, β2 and β5) and the immunoproteasome subunits (βi1, βi2 and βi5) (Fig 2A). Semi-quanti-
tative analysis of the RT-PCR bands showed a reduction of the mRNA (subunit/GADPH) of β1
(p<0.05), β2 (p<0.05), and no significant change for the β2i (p = 0.28) and β5i (p = 0.15) sub-
units in THP1MФi compared to THP1MФ with 14%, 25%, 9% and 25%, respectively (Fig 2B).
Fig 1. Uptake of Leishmania donovani by THP1MФ: effects on viability, and HLA-ABC, HLA-A02:01, HLA-DR
and CD83 expression. A) Flow cytometric analysis of the uptake of YFP-BHU5 by THP1MF assessed by the YFP
fluorescence in CD11b expressing THP1MFi compared to THP1MF, and viability of THP1MФ and THP1MФi
analyzed by calcein and PI staining. B) Expression levels of HLA-ABC, HLA-A02:01, HLA-DR and CD83 on
THP1MF and THP1MФi or THP1MФiy. C) Representation of the expression levels of HLA-ABC, HLA-A02:01,
HLA-DR and CD83 as fold change of MFI in THP1Mɸi or THP1Mɸiy below/above that of THP1Mɸ. Error bars
represent ±SD of the mean of three independent experiments; p< 0.05 comparing THP1MF vs THP1MФi or
THP1MФiy. Fig 1A and 1B are representatives of three independent experiments.
https://doi.org/10.1371/journal.pone.0200297.g001
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Self-ligands presented by HLA I of THP1MФ and THP1MFi
2.3 x 109 THP1MFi cells were lysed, and affinity chromatography and LC-MS/MS was used to
isolate the HLA class I molecules and analyze the HLA-bound peptides. A total of 86 non-
redundant HLA class I self-ligands were identified from 82 source proteins of THP1MФi (S1
Table) compared to 347 non-redundant HLA-I self-ligands derived from 282 source proteins
identified for 2.8 x 109 THP1MF cells at the same time and reported earlier [26]. Only 17
HLA-I self-peptide sequences and 18 source proteins were found to be shared between
THP1MФ and THP1MФi.
HLA I-bound peptide lengths
The HLA I-bound peptides were nonapeptides (55%, 59%), decapeptides (12%, 13%), octapep-
tides (7%, 8%), undecapetides (7%, 3%) and duodecapeptides (3%, 5%) in THP1MФ and
THP1MФi, respectively (Fig 3A). Thus, in both THP1MФ and THP1MФi the HLA I-bound
peptides were dominated by nonapeptides, though the percentage in THP1MФi was slightly
higher by 4%. Nonapeptides are the optimum lengths of HLA I-bound peptides [25, 26, 35–
37]. The slight increase of nonapeptides in THP1MФi compared to THP1MФ could suggest a
shift in antigen processing towards the more optimum peptide lengths for MHC I binding.
With 82%, nonapeptides were also the most dominant among the peptides shared between
THP1MФ and THP1MФi.
HLA assignment and binding affinities
The HLA restriction of the peptides was assigned using the netMHCpan in the immune epi-
tope database and the canonical peptide-binding motifs in the SYFPEITHI database [32]. In
THP1MF the percentage of the peptides identified were in the order
HLA-A02:01> HLA-B15:11> HLA-C03:03> unassigned with 35%, 33%, 19% and 13%
Fig 2. mRNA expression levels of constitutive proteasome subunits β1, β2 and β5 and the immunoproteasome
subunits βi1, βi2 and βi5 in THP1MФ and THP1MФi. A) Agarose gel electrophoresis of RT-PCR of the proteasome
subunits β1 (399bp), β2 (558bp) and β5 (275bp) and the immunoproteasome subunits βi1 (313bp), βi2 (571bp) and βi5
(648bp) in THP1MФ and THP1MФi, HeLa (positive control for constitutive proteasome subunits) and HeLa clone 33/
2 (positive control for immunoproteasome subunits), and GADPH as internal control. B) Shows mean ± SD of three
independent experiments of semi-quantified mRNA expression of proteasome subunits normalized to GADPH
mRNA expression in the same reaction using GelAnalyser 2010. p< 0.05 comparing THP1MF vs THP1MФi.
https://doi.org/10.1371/journal.pone.0200297.g002
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while in THP1MФi were in the order
HLA-B15:11 > HLA-C03:03> HLA-A02:01> unassigned with 52%, 20%, 17% and 10%,
respectively (Fig 3B). Thus, post infection the percentages of HLA-A02:01-bound peptides
decreased by 18% while those of HLA-B15:11 increased by 19%; those of HLA-C03:03 were
unaffected. For the HLA-I peptides shared between THP1MF and THP1MФi the percentages
were in the order HLA-B15:11> HLA-A02:01> HLA-C03:03 with 71%, 18% and 12%,
respectively. Binding affinity IC50 threshold of 500nM has been correlated to immunogenicity
[38]. We applied this threshold using the netMHCpan to determine the percentage HLA I pep-
tides (8-14mers) that could stimulate CD8 T cells. The percentages of peptides within this
threshold were HLA-A02:01 (52%, 53%), HLA-B15:11 (26%, 27%) and HLA-C03:03 (29%,
47%) in THP1MF and THP1MFi, respectively (Fig 3C). The percentage of HLA-B15:11 and
HLA-A02:01 peptides that had immune relevance in THP1MF and THP1MFi was approxi-
mately the same, despite 19% increase in HLA-B15:11- and 18% decrease in HLA-A02:01-
bound peptides identified in the infected cells. For HLA-C03:03, the percentage of peptides
that had immune relevance was higher in THP1MFi (47%) compared to THP1MF (29%),
though the total percentage of HLA-C03:03 peptides identified in THP1MFi and THP1MF
was about the same.
The binding motifs for HLA I in THP1MF and THP1MFi
To determine whether there was a difference in binding motifs of the nonapeptides in
THP1MF and THP1MFi, we used sequence logos [33, 34]. In these sequence logos, the height
of each column of amino acids is equal to the number of peptide sequences (in bits), and the
relative height of each amino acid within each column is proportional to the frequency of the
amino acid at that position. The most frequent primary anchor amino acids at position 2 of
infected and non-infected THP1MФ HLA-A02:01-bound peptides were L, and with about
equal but lower representation I, Y and M; for the C-terminus these were L and V. For
HLA-B15:11-bound peptides from infected and non-infected cells, P was most prominent at
position 2, and Y and F at the C-terminus followed by M in case of the infected cells. For
Fig 3. HLA class I self-peptide lengths, HLA restriction and binding affinities. A) HLA Class I peptide lengths in
THP1MF and THP1MFi. B) MHC restriction of HLA I-bound self-peptides from THP1MF and THP1MFi assigned
to HLA I alleles using the canonical binding motifs according to netMHCpan in the Immune Epitope Database (IEDB)
and SYFPEITHI. C) Cumulative percentage of THP1MF and THP1MFi HLA self-peptides within an IC50 threshold
of 500nM.
https://doi.org/10.1371/journal.pone.0200297.g003
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HLA-C03:03, A and Y were dominant at position 2 of peptides derived from non-infected
cells whereas no prominence was found at this position for peptides from infected cells. At the
C-terminus of HLA-C03:03-bound peptides, L was most frequent followed by F in non-
infected and M in infected THP1MФ (Fig 4).
Subcellular locations and biological functions of source proteins
The source proteins of the HLA I-bound peptides from THP1MF and THP1MFi were
assigned to the respective subcellular locations and biological functions using the human pro-
tein reference database [29]. The subcellular location of the source proteins from THP1MF
and THP1MFi were nucleus (34%, 21%), cytoplasm (23%, 16%), plasma membrane (9%,
21%), membrane (8%, 9%), endoplasmic reticulum (6%, 3%), mitochondrion (3%, 2%), extra-
cellular (1%, 8%), endosomes (1%, 1%), and Golgi apparatus (1%, 2%), respectively. For 5%
and 14% the subcellular locations were unknown (Fig 5A). In the infected cells, there was thus
Fig 4. Binding motifs for HLA I-bound self-peptides in THP1MF and THP1MFi. Sequence logos displaying the
amino acid preferences for HLA-A02:01-, HLA-B15:11- and HLA-C03:03-bound nonapeptides from THP1MF and
THP1MFi.
https://doi.org/10.1371/journal.pone.0200297.g004
Fig 5. Subcellular locations, biological and molecular functions of the source proteins of the HLA ligands. The
subcellular locations, biological and molecular functions of the source proteins of the HLA class I-bound peptides
identified by mass spectrometry from THP1MF and THP1MFi were assigned using the Human Protein Reference
Database. A) The subcellular locations. B) The biological and molecular functions.
https://doi.org/10.1371/journal.pone.0200297.g005
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an increase of source proteins from plasma membrane and extracellular proteins by 12% and
7%, and a decrease in source proteins from nucleus and cytoplasm by 13% and 7%, respec-
tively. In addition, no peptides were identified from source proteins from ribosomes, cytoskel-
eton and centrosome. The source proteins shared between THP1MФ and THP1MФi were
23% of the total source proteins in THP1MФi and 6% of the total source in THP1MФ and
were from almost all subcellular locations in the cell.
The biological functions of the source proteins in THP1MF and THP1MFi were cell com-
munication/signal transduction (16%, 20%), protein metabolism (21%, 8%), transcription/
transcription regulation (10%, 9%), transport (7%, 8%), metabolism/energy pathways (5%,
8%), cell growth and/or maintenance (10%, 8%), RNA binding (7%, 2%), immune response
(3%, 9%), and DNA binding (3%, 3%), respectively. 7% and 16% of the source proteins had no
known biological functions (Fig 5B). Post infection the percentage of source proteins involved
in immune response, cell communication/signal transduction and metabolism/energy path-
ways increased by 6%, 4% and 3%, while those involved in protein metabolism, RNA binding,
cell growth and/or maintenance decreased by 13%, 5% and 2%, respectively. The source pro-
teins shared between THP1MФ and THP1MФi were mostly involved in cell communications/
signal transduction (25%) and protein metabolism (15%).
Discussion
The total number of HLA class I-restricted self-peptides and source proteins identified from
THP1MFi was four-fold lower compared to those identified in THP1MF, and were heteroge-
neous and individualized. Only a few peptides were found to be shared between the two
despite expressing the same HLA alleles.
The strong decrease in the number of HLA class I-restricted peptides from LD-infected
THP1MФ has been reproduced in independent experiments and thus not a technical issue,
but may rather be due to the following. Firstly, the overall MHC-I expression at the cell surface
of THP1MФi was lower compared to THP1MФ including, though not significantly, that of
HLA-A02:01 (Fig 1B and 1C). Reduction of MHC I-restricted antigen presentation upon
infection with LD parasites through reduction of MHC I present at the cell surface has also
been observed in murine studies albeit no comparative peptidome studies had been done [14,
39]. Though our focus was on HLA I-restricted self-peptides, we also observed lower expres-
sion of HLA II by THP1MФi compared to THP1MФ. This observation concurred with murine
studies on MHC II, and showed that Leishmania inhibits antigen presentation by repressing
MHC II expression [14, 39, 40]. Secondly, the infection of THP1MФ by LD resulted in a slight
decrease in host cell viability (Fig 1A), which might be due to the fact that naturally Leish-
mania promastigotes, upon uptake by macrophages, transform to amastigotes and multiply to
eventually rupture the macrophages [2]. Thirdly, although CD83 expression, a marker of mac-
rophage activation, was unchanged in THP1MФi compared to THP1MФ indicating a lack of
activation, LD infection resulted in decreased expression of β1 and β2 constitutive proteasome
subunits, which could translate into decreased antigen processing efficiency. The impact of
proteasome on the quality and quantity of MHC class I ligands had been studied using wild
type and proteasome subunits deficient murine dendritic cells [41, 42]: expression of protea-
some subunits correlated with increased generation of peptides that are suitable for binding to
MHC I molecules.
The heterogeneity and individuality in the HLA I self-peptides and source proteins identi-
fied in THP1MФ and THP1MФi depicts differences in protein expression, processing and pre-
sentation, as was in other cells and tumor samples [25, 26, 35, 36]. The nonapeptides are the
optimum lengths for MHC class I binding [26] and though the infection of THP1MФ by LD
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did not change the nonapeptides dominance in the identified HLA I-bound peptides, pro-
found differences in antigen processing and presentation were evident, firstly, in the HLA
restriction of identified peptides. For THP1MF the percentage of the peptides identified for
the different HLA-restrictions ranked in the order
HLA-A02:01> HLA-B15:11> HLA-C03:03 while in THP1MФi they were in the order
HLA-B15:11 > HLA-C03:03> HLA-A02:01. Though HLA-B15:11 peptides were domi-
nant after infection with LD, only 26% of them were within the IC50 threshold of 500nM. In
general, after infection there was a shift of peptides towards lower affinity binders. A previous
systematic mapping and characterizing of peptide ligands derived from B1508, B1501,
B1503, and B1510 showed endogenous peptide loaded into B15 to be flexible both in the
location of and amino acids at the N-proximal anchors [43]. In addition to this, additional
preference of aliphatic amino acids was observed at the C-Terminus after infection, which
would, though unconfirmed in Prilliman et al. [43], result in lower binding affinity of the pep-
tides. The differences in antigen processing and presentation were evident in the peptide
anchor motifs. For the HLA-A02:01-bound peptides there were no dominant accessory
anchor amino acids at position 6 in THP1MФi compared to the dominant hydrophobic
anchor in THP1MФ. For HLA-C03:03 there was no anchor motifs at position 2 in THP1MФi
but a strong preference for A and Y in THP1MФ but a higher percentage of peptides within
the IC50 threshold of 500nM in THP1MФi compared to THP1MФ.
In both THP1MF and THP1MFi the peptide source proteins were derived from almost all
subcellular locations and were involved in almost all molecular functions of the cells. But dif-
ferences were observed. Firstly, in THP1MFi compared to THP1MF, there was an increase of
source proteins from plasma membrane and extracellular proteins and a decrease in source
proteins from nucleus and cytoplasm (Fig 5A), and no peptides were identified from ribo-
somes, cytoskeleton and centrosomes unlike in THP1MF. Secondly, in THP1MFi compared
to THP1MF, there was an increase of source proteins involved in immune responses, cell
communication/signal transduction and metabolism/energy pathways and a decrease in those
involved in protein metabolism, RNA binding, cell growth and/or maintenance (Fig 5B). The
differences in source protein peptide sampling in THP1MF and THP1MFi, would imply dif-
ferences in protein turnover, as protein turnover correlates with source protein presentation
[44, 45]. LD has been shown previously in proteomic studies to globally alter protein expres-
sion in THP1 cells [46].
In summary, the infection of macrophages with LD has profound effects on the self-peptide
repertoire presented by MHC I molecules, which in parts can be explained with changes in
antigen processing including the composition of the proteasomes, and altered protein expres-
sion and turn-over in different cellular compartments. In conclusion, the self-displayed by
infected macrophages is very different from the self of uninfected cells. This difference may
relate to T cell-mediated autoimmune reactions which may explain some of the immune
pathology observed in LD patients, as changes in self-peptidome have been shown previously
to impact T cell-mediated immune responses [47, 48]. Furthermore, though our focus was on
the self-antigens, also the processing of LD antigens may be affected but likely not in the same
manner as the self-antigens. LD antigens as exogenous antigensare processed via the MHC
class I cross-presentation pathway whereas the self-antigens as endogenous antigens are pro-
cessed via the classical MHC class I antigen processing and presentation pathway [49, 50]. To
check for alterations, a comparison of LD MHC I peptidomes from THP1 derived macro-
phages incubated with dead LD versus infected with live LD would be required. The results of
such studies would however be difficult to compare because dead parasite are expected to be
processed through the MHC class II antigen-processing pathway in endolysosomes and the
epitopes primarily be presented by MHC class II molecules. Lastly, LD and HIV infect the
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same host cells, macrophages, but differently, and persist in different subcellular compart-
ments and use different survival mechanisms that affect different key players in the MHC class
I antigen processing and presentation pathways [8, 14, 39, 51–54]. LD/HIV co-infection is
expected to result in mutual impact on processing and presentation of antigens of both agents.
Given the increased fatality of HIV/VL co-infection cases, determination of the effect of LD/
HIV co-infection on the self-peptidomes as well as HLA peptidomes of the pathogens, which
are yet to be determined, would be vital.
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